About Johnson & Johnson Innovative Medicine
Johnson & Johnson Innovative Medicine is a company based in Raritan (United States) founded in 1953. It operates as a Professional Services, and Direct-to-Consumer (D2C). Johnson & Johnson Innovative Medicine has completed 5 acquisitions, including Anakuria Therapeutics, Corimmun and Johnson & Johnson Innovative Medicine. Johnson & Johnson Innovative Medicine offers products and services including INLEXZO™, DARZALEX®, Icotrokinra, and Seltorexant.
- Headquarter Raritan, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Johnson & Johnson And Its Affiliates
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Anakuria Therapeutics
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Johnson & Johnson Innovative Medicine
Johnson & Johnson Innovative Medicine offers a comprehensive portfolio of products and services, including INLEXZO™, DARZALEX®, Icotrokinra, and Seltorexant. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug releasing system for bladder cancer treatment locally.
Treatment for high-risk smouldering multiple myeloma patients.
Oral peptide for moderate-to-severe plaque psoriasis treatment.
Adjunctive treatment for major depressive disorder symptoms.
Unlock access to complete
Unlock access to complete
Software Development Team
294 people
Leadership Team
141 people
Senior Team
50 people
Finance and Accounting
45 people
Data Analysis and Operations Team
41 people
Product Management Team
26 people
Legal and Compliance
26 people
Human Resources and Administration
26 people
Unlock access to complete
Funding Insights of Johnson & Johnson Innovative Medicine
- Total Funding Total Funding
- Total Rounds 19
- Last Round Last Round
-
First Round
First Round
(01 Jan 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Grant - Johnson & Johnson Innovative Medicine | Valuation |
investors |
|
| Sep, 2021 | Amount | Grant - Johnson & Johnson Innovative Medicine | Valuation |
investors |
|
| Jun, 2021 | Amount | Grant - Johnson & Johnson Innovative Medicine | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Johnson & Johnson Innovative Medicine
Johnson & Johnson Innovative Medicine has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Johnson & Johnson Innovative Medicine
Johnson & Johnson Innovative Medicine has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Anakuria Therapeutics, Corimmun and Johnson & Johnson Innovative Medicine. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Anti-thrombin antibody to treat heart attacks and strokes
|
2012 | ||||
|
Oncolytic virotherapies are developed for solid tumor treatment.
|
2011 | ||||
|
Small molecule drugs for patients with Chronic Obstructive Pulmonary Disease, Cystic Fibrosis and severe asthma.
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Johnson Johnson Innovative Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Johnson & Johnson Innovative Medicine Comparisons
Competitors of Johnson & Johnson Innovative Medicine
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Johnson & Johnson Innovative Medicine
Frequently Asked Questions about Johnson & Johnson Innovative Medicine
When was Johnson & Johnson Innovative Medicine founded?
Johnson & Johnson Innovative Medicine was founded in 1953 and raised its 1st funding round 62 years after it was founded.
Where is Johnson & Johnson Innovative Medicine located?
Johnson & Johnson Innovative Medicine is headquartered in Raritan, United States. It is registered at Raritan, New Jersey, United States.
Who is the current CEO of Johnson & Johnson Innovative Medicine?
Tom Heyman is the current CEO of Johnson & Johnson Innovative Medicine.
What does Johnson & Johnson Innovative Medicine do?
Johnson Johnson Innovative Medicine is focused on developing transformational medicines in areas such as oncology, immunology, neuroscience, and cardiopulmonary health. Solutions are created through rigorous scientific research and global expertise to address devastating diseases. The company is committed to pioneering treatments that change how diseases are managed and cured, delivering hope to millions of patients worldwide. Investments in state-of-the-art facilities and groundbreaking therapies are prioritized to enhance healthcare delivery.
What products or services does Johnson & Johnson Innovative Medicine offer?
Johnson & Johnson Innovative Medicine offers INLEXZO™, DARZALEX®, Icotrokinra, and Seltorexant.
How many acquisitions has Johnson & Johnson Innovative Medicine made?
Johnson & Johnson Innovative Medicine has made 5 acquisitions, including Anakuria Therapeutics, Corimmun, and Johnson & Johnson Innovative Medicine.
Who are Johnson & Johnson Innovative Medicine's investors?
Johnson & Johnson Innovative Medicine has 1 investor. Key investors include European Union.